Chest ACCP Career Connection
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kohno, N
Right arrow Articles by Akiyama, M
Right arrow Search for Related Content
PubMed
Right arrow Articles by Kohno, N
Right arrow Articles by Akiyama, M

Chest, Vol 96, 68-73, Copyright © 1989 by American College of Chest Physicians

ARTICLES

New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6

N Kohno, S Kyoizumi, Y Awaya, H Fukuhara, M Yamakido and M Akiyama
Department of Radiobiology, Radiation Effects Research Foundation, Hiroshima, Japan.

Serum levels of a high molecular weight circulating antigen KL-6, detected by means of a sandwich assay using a monoclonal antibody KL-6 against a sialylated carbohydrate antigen, were evaluated for usefulness in monitoring the activity of interstitial pneumonitis. Abnormally high levels of KL-6 antigen were observed in the sera of 34 (58 percent) of 59 patients with interstitial pneumonitis. There was no significant correlation between serum values of KL-6 antigen and LDH activity. There was a positive correlation between KL-6 antigen levels and the degree of clinical disease activity as measured by 67Ga-citrate scintigram and the clinical course. Though this is a preliminary study, these observations suggest that the serum level of KL-6 antigen may be a useful indicator of disease activity in patients with interstitial pneumonitis. It does not appear to be useful, however, in the differential diagnosis of interstitial pneumonitis from malignant and nonmalignant diseases.


This article has been cited by other articles:


Home page
 Br. J. Ophthalmol.Home page
S Kase, N Kitaichi, N Furudate, K Yoshida, and S Ohno
Increased expression of mucinous glycoprotein KL-6 in human pterygium.
Br. J. Ophthalmol., September 1, 2006; 90(9): 1208 - 1209.
[Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
R. Janssen, A. Kruit, J. C. Grutters, H. J. Ruven, W. B. Gerritsen, and J. M. van den Bosch
The Mucin-1 568 Adenosine to Guanine Polymorphism Influences Serum Krebs von den Lungen-6 levels
Am. J. Respir. Cell Mol. Biol., April 1, 2006; 34(4): 496 - 499.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
K. Kashiwabara
Characteristics and disease activity of early interstitial lung disease in subjects with true parenchymal abnormalities in the posterior subpleural aspect of the lung.
Chest, February 1, 2006; 129(2): 402 - 406.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
W.-J. P. van Boven, W. B. M. Gerritsen, P. Zanen, J. C. Grutters, H. P. A. van Dongen, A. Bernard, and L. P. H. J. Aarts
Pneumoproteins as a Lung-Specific Biomarker of Alveolar Permeability in Conventional On-pump Coronary Artery Bypass Graft Surgery vs Mini-Extracorporeal Circuit: A Pilot Study
Chest, April 1, 2005; 127(4): 1190 - 1195.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
S. Homma, A. Miyamoto, S. Sakamoto, K. Kishi, N. Motoi, and K. Yoshimura
Pulmonary fibrosis in an individual occupationally exposed to inhaled indium-tin oxide
Eur. Respir. J., January 1, 2005; 25(1): 200 - 204.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
Q. A. Al-Salmi, J. N. Walter, G. N. Colasurdo, M. M. Sockrider, E. O. Smith, H. Takahashi, and L. L. Fan
Serum KL-6 and Surfactant Proteins A and D in Pediatric Interstitial Lung Disease
Chest, January 1, 2005; 127(1): 403 - 407.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. Ishizaka, T. Matsuda, K. H. Albertine, H. Koh, S. Tasaka, N. Hasegawa, N. Kohno, T. Kotani, H. Morisaki, J. Takeda, et al.
Elevation of KL-6, a lung epithelial cell marker, in plasma and epithelial lining fluid in acute respiratory distress syndrome
Am J Physiol Lung Cell Mol Physiol, June 1, 2004; 286(6): L1088 - L1094.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
K. Saito, S. Nakayamada, K. Nakano, M. Tokunaga, S. Tsujimura, K. Nakatsuka, T. Adachi, and Y. Tanaka
Detection of Pneumocystis carinii by DNA amplification in patients with connective tissue diseases: re-evaluation of clinical features of P. carinii pneumonia in rheumatic diseases
Rheumatology, April 1, 2004; 43(4): 479 - 485.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
R. Hara, J. Itami, T. Komiyama, D. Katoh, and T. Kondo
Serum Levels of KL-6 for Predicting the Occurrence of Radiation Pneumonitis After Stereotactic Radiotherapy for Lung Tumors
Chest, January 1, 2004; 125(1): 340 - 344.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
R. Janssen, H. Sato, J. C. Grutters, A. Bernard, H. van Velzen-Blad, R. M. du Bois, and J. M. M. van den Bosch
Study of Clara Cell 16, KL-6, and Surfactant Protein-D in Serum as Disease Markers in Pulmonary Sarcoidosis
Chest, December 1, 2003; 124(6): 2119 - 2125.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
H Ohnishi, A Yokoyama, Y Yasuhara, A Watanabe, T Naka, H Hamada, M Abe, K Nishimura, J Higaki, J Ikezoe, et al.
Circulating KL-6 levels in patients with drug induced pneumonitis
Thorax, October 1, 2003; 58(10): 872 - 875.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
H Ishii, H Mukae, J Kadota, H Kaida, T Nagata, K Abe, S Matsukura, and S Kohno
High serum concentrations of surfactant protein A in usual interstitial pneumonia compared with non-specific interstitial pneumonia
Thorax, January 1, 2003; 58(1): 52 - 57.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
K. H. Albertine, M. F. Soulier, Z. Wang, A. Ishizaka, S. Hashimoto, G. A. Zimmerman, M. A. Matthay, and L. B. Ware
Fas and Fas Ligand Are Up-Regulated in Pulmonary Edema Fluid and Lung Tissue of Patients with Acute Lung Injury and the Acute Respiratory Distress Syndrome
Am. J. Pathol., November 1, 2002; 161(5): 1783 - 1796.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
H Yasuda, M Yamaya, M Yanai, T Ohrui, and H Sasaki
Increased blood carboxyhaemoglobin concentrations in inflammatory pulmonary diseases
Thorax, September 1, 2002; 57(9): 779 - 783.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
H. OHNISHI, A. YOKOYAMA, K. KONDO, H. HAMADA, M. ABE, K. NISHIMURA, K. HIWADA, and N. KOHNO
Comparative Study of KL-6, Surfactant Protein-A, Surfactant Protein-D, and Monocyte Chemoattractant Protein-1 as Serum Markers for Interstitial Lung Diseases
Am. J. Respir. Crit. Care Med., February 1, 2002; 165(3): 378 - 381.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
I. Kobayashi, M. Yamada, Y. Takahashi, N. Kawamura, M. Okano, Y. Sakiyama, and K. Kobayashi
Interstitial lung disease associated with juvenile dermatomyositis: clinical features and efficacy of cyclosporin A
Rheumatology, February 1, 2002; 42(2): 371 - 374.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
M. Narita, H. Tanaka, S. Abe, S. Yamada, M. Kubota, and T. Togashi
Close Association between Pulmonary Disease Manifestation in Mycoplasma pneumoniae Infection and Enhanced Local Production of Interleukin-18 in the Lung, Independent of Gamma Interferon
Clin. Vaccine Immunol., November 1, 2000; 7(6): 909 - 914.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
Y. Ogawa, T. Ishikawa, K. Ikeda, B. Nakata, T. Sawada, K. Ogisawa, Y. Kato, and K. Hirakawa
Evaluation of Serum KL-6, a Mucin-like Glycoprotein, as a Tumor Marker for Breast Cancer
Clin. Cancer Res., October 1, 2000; 6(10): 4069 - 4072.
[Abstract] [Full Text]

Home page
 ChestHome page
T. Takahashi, M. Munakata, Y. Ohtsuka, A. Satoh-Kamachi, R. Sato, Y. Homma, and Y. Kawakami
Serum KL-6 Concentrations in Dairy Farmers
Chest, August 1, 2000; 118(2): 445 - 450.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
M. Kubo, H. Ihn, K. Yamane, K. Kikuchi, N. Yazawa, Y. Soma, and K. Tamaki
Serum KL-6 in adult patients with polymyositis and dermatomyositis
Rheumatology, June 1, 2000; 39(6): 632 - 636.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
S. Bandoh, J. Fujita, Y. Ohtsuki, Y. Ueda, S. Hojo, M. Tokuda, H. Dobashi, N. Kurata, T. Yoshinouchi, N. Kohno, et al.
Sequential changes of KL-6 in sera of patients with interstitial pneumonia associated with polymyositis/dermatomyositis
Ann Rheum Dis, April 1, 2000; 59(4): 257 - 262.
[Abstract] [Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
Y. HIRASAWA, N. KOHNO, A. YOKOYAMA, K. KONDO, K. HIWADA, and M. MIYAKE
Natural Autoantibody to MUC1 Is a Prognostic Indicator for Non-Small Cell Lung Cancer
Am. J. Respir. Crit. Care Med., February 1, 2000; 161(2): 589 - 594.
[Abstract] [Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
C. HERMANS and A. BERNARD
Lung Epithelium-specific Proteins . Characteristics and Potential Applications as Markers
Am. J. Respir. Crit. Care Med., February 1, 1999; 159(2): 646 - 678.
[Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. YOKOYAMA, N. KOHNO, H. HAMADA, M. SAKATANI, E. UEDA, K. KONDO, Y. HIRASAWA, and K. HIWADA
Circulating KL-6 Predicts the Outcome of Rapidly Progressive Idiopathic Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med., November 1, 1998; 158(5): 1680 - 1684.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
T. TAKAHASHI, M. MUNAKATA, I. SUZUKI, and Y. KAWAKAMI
Serum and Bronchoalveolar Fluid KL-6 Levels in Patients with Pulmonary Alveolar Proteinosis
Am. J. Respir. Crit. Care Med., October 1, 1998; 158(4): 1294 - 1298.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
M. Nakajima, T. Manabe, Y. Niki, and T. Matsushima
Serum KL-6 level as a monitoring marker in a patient with pulmonary alveolar proteinosis
Thorax, September 1, 1998; 53(9): 809 - 811.
[Abstract] [Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
J.-Y. SHIH, S.-C. YANG, C.-J. YU, H.-D. WU, Y.-S. LIAW, R. WU, and P.-C. YANG
Elevated Serum Levels of Mucin-associated Antigen in Patients with Acute Respiratory Distress Syndrome
Am. J. Respir. Crit. Care Med., November 1, 1997; 156(5): 1453 - 1457.
[Abstract] [Full Text]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
Y. Hirasawa, N. Kohno, A. Yokoyama, Y. Inoue, M. Abe, and K. Hiwada
KL-6, a Human MUC1 Mucin, Is Chemotactic for Human Fibroblasts
Am. J. Respir. Cell Mol. Biol., October 1, 1997; 17(4): 501 - 507.
[Abstract] [Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
Y. Inoue, E. Barker, E. Daniloff, N. Kohno, K. Hiwada, and L. S. Newman
Pulmonary Epithelial Cell Injury and Alveolar-Capillary Permeability in Berylliosis
Am. J. Respir. Crit. Care Med., July 1, 1997; 156(1): 109 - 115.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by the American College of Chest Physicians.